Lead Product(s) : Misoprostol
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Cameroon Baptist Convention Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Use Misoprostol to Optimize Prevention of Cervical Cancer
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Uterine Cervical Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 01, 2024
Lead Product(s) : Misoprostol
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Cameroon Baptist Convention Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Postoperative Hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 21, 2023
Lead Product(s) : Misoprostol
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : Nabiqasim Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Non-alcoholic Fatty Liver Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 07, 2023
Lead Product(s) : Misoprostol
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : Nabiqasim Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 04, 2020
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Buccal Versus Vaginal Misoprostol In Combination With Foley Bulb
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Labor, Induced.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 05, 2019
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : National Committee for Maternal & Neonatal Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postpartum Hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 03, 2016
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : National Committee for Maternal & Neonatal Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Department of Medical Research, Lower Myanmar
Deal Size : Inapplicable
Deal Type : Inapplicable
Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 14, 2016
Lead Product(s) : Misoprostol
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Department of Medical Research, Lower Myanmar
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Pregnancy.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 24, 2014
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : Gynuity Health Projects
Deal Size : Inapplicable
Deal Type : Inapplicable
Immune Modulation by Misoprostol
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Female Urogenital Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 08, 2014
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : Gynuity Health Projects
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Ministry of Health and Population, Egypt | University of Alexandria | El Galaa Teaching Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Misoprostol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postpartum Hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 27, 2014
Lead Product(s) : Misoprostol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Ministry of Health and Population, Egypt | University of Alexandria | El Galaa Teaching Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
